Michael Kata
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Spectroscopy top 10%
- Analytical Chemistry and Chromatography
Papers in
-
- Drug Solubulity and Delivery Systems 23
- Spectroscopy 11
- Analytical Chemistry and Chromatography 11
- Molecular Sensors and Ion Detection 3
- Co-authors
- Istvan EROS (2 shared papers)Géza Regdon (4 shared papers)Piroska Szabó‐Révész (1 shared paper)Z. Aigner (7 shared papers)Ottó Berkesi (4 shared papers)Tamer Güneri (5 shared papers)J. L. Vila-Jato (1 shared paper)Juan José Torres-Labandeira (1 shared paper)
In The Last Decade
Michael Kata
36 papers receiving 476 citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 226
- Spectroscopy 81
- Analytical Chemistry 45
- Biomaterials 58
- Food Science 76
Countries citing papers authored by Michael Kata
This map shows the geographic impact of Michael Kata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kata more than expected).
Fields of papers citing papers by Michael Kata
This network shows the impact of papers produced by Michael Kata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kata. The network helps show where Michael Kata may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 129 | |
| 2 | 2001 | 51 | |
| 3 | 1994 | 43 | |
| 4 | 2002 | 30 | |
| 5 | 2000 | 25 | |
| 6 | 2005 | 24 | |
| 7 | 2004 | 20 | |
| 8 | 2003 | 17 | |
| 9 | 2003 | 14 | |
| 10 | 2003 | 11 | |
| 11 | 1991 | 11 | |
| 12 | The activity of rat brain nitric oxide synthase following chronic antidepressant treatment. | 2000 | 11 |
| 13 | 1999 | 11 | |
| 14 | 1987 | 11 | |
| 15 | Enhancement of solubility of vinpocetine base with gamma-cyclodextrin. | 1986 | 10 |
| 16 | Chronic electroconvulsive treatment increases the activity of nitric oxide synthase in the rat brain. | 1998 | 9 |
| 17 | Increasing the solubility characteristics of albendazole with dimethyl-beta-cyclodextrin. | 1991 | 9 |
| 18 | 1998 | 7 | |
| 19 | 1995 | 7 | |
| 20 | 1999 | 5 |
About Michael Kata
Michael Kata is a scholar working on Pharmaceutical Science, Spectroscopy, Analytical Chemistry, Materials Chemistry and Food Science, having authored 39 papers that have together received 492 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (23 papers), Crystallization and Solubility Studies (14 papers), Analytical Chemistry and Chromatography (11 papers), Analytical Methods in Pharmaceuticals (5 papers), Protein purification and stability (4 papers), Molecular Sensors and Ion Detection (3 papers), Synthesis and properties of polymers (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Pharmaceutical Science (226 citations), Spectroscopy (81 citations), Analytical Chemistry (45 citations), Biomaterials (58 citations) and Food Science (76 citations). Michael Kata has collaborated with scholars based in Hungary, Türkiye and Poland. Frequent co-authors include Istvan EROS, Géza Regdon, Piroska Szabó‐Révész, Z. Aigner, Ottó Berkesi, Tamer Güneri, J. L. Vila-Jato, Juan José Torres-Labandeira, Imre Dékány and Gabriel Nowak. Their work appears in journals such as Journal of Thermal Analysis and Calorimetry, Starch - Stärke, Colloid & Polymer Science, Journal of Neural Transmission and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.